Business Context and Reporting Period
This Form 8-K was filed by TenX Keane Acquisition (not Citius Oncology, Inc.) on October 18, 2023. The registrant is a Cayman Islands-based special purpose acquisition company (SPAC) listed on The Nasdaq Stock Market LLC under the symbols TENKU, TENK, and TENKR. The report details the extension of the deadline to complete its initial business combination.
Key Financial Metrics
The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, or margins, as the company is a pre-business combination SPAC. Key financial data points include:
- Extension Fee: $660,000 deposited into the trust account.
- Promissory Note Principal: $660,000 issued to the Sponsor (10XYZ Holdings LP).
- Interest Rate: 0% (non-interest bearing).
- Conversion Option: The Sponsor may convert up to $1,500,000 of the note into private units at $10.00 per unit.
Material Changes
The primary material change is the extension of the timeline to consummate a business combination. The deadline has been extended by three months from October 18, 2023, to January 18, 2024. This extension was facilitated by the deposit of the $660,000 Extension Fee, evidenced by an unsecured promissory note payable upon the consummation of the business combination.
Outlook, Risks, and Contingencies
Outlook: The company now has until January 18, 2024, to complete its initial business combination. The filing notes that the company may extend the period up to two times total, subject to further deposits.
Risks and Contingencies: The promissory note contains specific events of default, including failure to pay within five business days of the maturity date, bankruptcy proceedings, or breach of obligations. In the event of default, the note may be accelerated. The issuance of the note was made pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
Investor Verification Checklist
- Verify the exact deadline for the initial business combination (January 18, 2024).
- Confirm the terms of the $660,000 promissory note and the Sponsor's right to convert up to $1,500,000 into units.
- Review the attached Press Release (Exhibit 99.1) for additional context on the extension.
- Monitor future filings for any additional extension fees required to extend the timeline beyond January 18, 2024.